drugset / Trial / NCT00840203
Mesalamine 4 gm/60 mL Rectal Enema
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to evaluate the relative bioavailability of the test formulation of mesalamine suspension rectal enema with the already marketed reference formulation Rowasa® in healthy, adult subjects.
Timeline
- Start
- 2003-05
- Primary completion
- 2003-06
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | 4 g | Rectal |
Indications
No indication recorded.